The Therapeutic Goods
Administration has announced
that it will update the Australian
approved names of ingredients
used in medicines to better align
with international standards,
as part of its international
harmonisation plans.
There will be a four year transition
period for the changes which is
expected to commence in Apr 2016.
While some changes are minor
- such as changing a ‘y’ to an
‘i’ which won’t affect how the
ingredient name is pronounced,
others are more significant and in
these cases medicine labels will
be required to use both the old
and new ingredient names for an
additional three years after the end
of the transition period.
The full list of name changes can
be viewed at www.tga.gov.au.
MEANWHILE the TGA has also
issued a warning about some
“home based” beauty salons which
may be using imported Botox which
has not been approved for supply
within Australia.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Nov 15
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.